BPCE
Bank Pictet & Cie (Europe) Portfolio holdings
AUM
$4.68B
This Quarter Return
-4.12%
1 Year Return
+16.47%
3 Year Return
+101.24%
5 Year Return
+155.05%
10 Year Return
+381.72%
AUM
$2.03B
AUM Growth
+$2.03B
(-6.1%)
Cap. Flow
+$166M
Cap. Flow
% of AUM
8.17%
Top 10 Holdings %
Top 10 Hldgs %
46.04%
Holding
174
New
16
Increased
40
Reduced
63
Closed
8
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$128M |
| 2 |
Alphabet (Google) Class C
GOOG
|
$45.7M |
| 3 |
VanEck Oil Services ETF
OIH
|
$42.2M |
| 4 |
Weatherford International
WFRD
|
$26.5M |
| 5 |
NovaGold Resources
NG
|
$24.7M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$32.1M |
| 2 |
Apple
AAPL
|
$27.8M |
| 3 |
Amazon
AMZN
|
$16.3M |
| 4 |
PepsiCo
PEP
|
$13.9M |
| 5 |
Starbucks
SBUX
|
$12.9M |
Sector Composition
| 1 | Healthcare | 24.27% |
| 2 | Technology | 14.64% |
| 3 | Consumer Discretionary | 14.33% |
| 4 | Communication Services | 12.28% |
| 5 | Financials | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Walmart
WMT
$774B
| $1.03M | 0.05% | 7,950 +350 | +5% | +$45.4K |
|
102
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.8B
| $1.01M | 0.05% | 16,280 | – | – |
|
103
Gilead Sciences
GILD
$140B
| $989K | 0.05% | 16,025 +1,500 | +10% | +$92.5K |
|
104
Verizon
VZ
$186B
| $908K | 0.04% | 23,925 | – | – |
|
105
Becton Dickinson
BDX
$55.3B
| $891K | 0.04% | 4,000 -2,100 | -34% | -$468K |
|
106
Edwards Lifesciences
EW
$47.8B
| $821K | 0.04% | 9,935 -246 | -2% | -$20.3K |
|
107
Bristol-Myers Squibb
BMY
$96B
| $800K | 0.04% | 11,250 | – | – |
|
108
Sea Limited
SE
$110B
| $776K | 0.04% | 13,851 +1,160 | +9% | +$65K |
|
109
Vertex Pharmaceuticals
VRTX
$100B
| $755K | 0.04% | 2,607 -599 | -19% | -$173K |
|
110
Dropbox
DBX
$7.84B
| $755K | 0.04% | 36,415 | – | – |
|
111
Boston Scientific
BSX
$156B
| $717K | 0.04% | 18,515 -8,734 | -32% | -$338K |
|
112
IBM
IBM
$227B
| $696K | 0.03% | +5,860 | New | +$696K |
|
113
Logitech
LOGI
$15.3B
| $679K | 0.03% | 14,534 +134 | +0.9% | +$6.26K |
|
114
Biogen
BIIB
$19.4B
| $678K | 0.03% | 2,539 +23 | +0.9% | +$6.14K |
|
115
Lockheed Martin
LMT
$106B
| $618K | 0.03% | 1,600 | – | – |
|
116
SOPHiA GENETICS
SOPH
$234M
| $599K | 0.03% | 227,600 | – | – |
|
|
GB
117
DELISTED
Global Blue Group Holding
GB
| $595K | 0.03% | 128,571 | – | – |
|
118
Intel
INTC
$107B
| $579K | 0.03% | 22,478 +1,200 | +6% | +$30.9K |
|
119
TJX Companies
TJX
$152B
| $558K | 0.03% | 8,988 | – | – |
|
120
Apellis Pharmaceuticals
APLS
$3.48B
| $498K | 0.02% | 7,297 | – | – |
|
121
Natera
NTRA
$23.1B
| $478K | 0.02% | 10,915 -1,291 | -11% | -$56.6K |
|
122
Stryker
SYK
$150B
| $460K | 0.02% | 2,269 +286 | +14% | +$57.9K |
|
123
iShares MSCI India ETF
INDA
$9.17B
| $442K | 0.02% | 10,827 | – | – |
|
124
Goldman Sachs
GS
$226B
| $431K | 0.02% | 1,470 | – | – |
|
125
Castle Biosciences
CSTL
$696M
| $416K | 0.02% | +15,957 | New | +$416K |
|